Results 201 to 210 of about 7,735 (257)

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. [PDF]

Signal Transduct Target Ther
Pan QZ, Zhao JJ, Liu L, Zhang DS, Wang LP, Hu WW, Weng DS, Xu X, Li YZ, Tang Y, Zhang WH, Li JY, Zheng X, Wang QJ, Li YQ, Xiang T, Zhou L, Yang SN, Wu C, Huang RX, He J, Du WJ, Chen LJ, Wu YN, Xu B, Shen Q, Zhang Y, Jiang JT, Ren XB, Xia JC.   +29 more
europepmc   +1 more source

SIRT3‐dependent GOT2 acetylation status affects the malate–aspartate NADH shuttle activity and pancreatic tumor growth

EMBO Journal, 2015
Hui Yang, Li-sha Zhou, Q. Shi, Yuzheng Zhao, Huaipeng Lin, Mengli Zhang, Shimin Zhao, Yi Yang, Z. Ling, K. Guan, Y. Xiong, D. Ye   +11 more
semanticscholar   +1 more source

Chemotherapy-Induced Changes in Plasma Amino Acids and Lipid Oxidation of Resected Patients with Colorectal Cancer: A Background for Future Studies. [PDF]

Int J Mol Sci
Aquilani R, Brugnatelli S, Maestri R, Iadarola P, Corallo S, Pagani A, Serra F, Bellini A, Buonocore D, Dossena M, Boschi F, Verri M.   +11 more
europepmc   +1 more source

Efficacy of XELOX adjuvant chemotherapy for gastric mixed adenoneuroendocrine carcinoma: A case report. [PDF]

Medicine (Baltimore), 2019
Lin Z, Chen J, Guo Y.
europepmc   +1 more source

A universal metabolite repair enzyme removes a strong inhibitor of the TCA cycle. [PDF]

Nat Commun
Zmuda AJ, Kang X, Wissbroecker KB, Freund Saxhaug K, Costa KC, Hegeman AD, Niehaus TD.   +6 more
europepmc   +1 more source

Tolerability and pharmacokinetics of oxaloacetate 100mg capsules in Alzheimer's subjects

, 2016
Russell H. Swerdlow, Rebecca Bothwell, Lewis Hutfles, Jeffrey M. Burns, Gregory A. Reed   +4 more
openalex   +1 more source

Bacillus subtilis YisK possesses oxaloacetate decarboxylase activity and exhibits Mbl-dependent localization. [PDF]

J Bacteriol
Guo T, Sperber AM, Krieger IV, Duan Y, Chemelewski VR, Sacchettini JC, Herman JK.   +6 more
europepmc   +1 more source

Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer. [PDF]

Cancer Med, 2020
Wang DS, Wang ZQ, Chen G, Peng JW, Wang W, Deng YH, Wang FH, Zhang JW, Liang HL, Feng F, Xie CB, Ren C, Jin Y, Shi SM, Fan WH, Lu ZH, Ding PR, Wang F, Xu RH, Li YH.   +19 more
europepmc   +1 more source

Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1

, 2018
Alexander K. H. Weiss, Andreas Naschberger, Johannes R. Loeffler, Hubert Gstach, Matthew W. Bowler, Max Holzknecht, Elia Cappuccio, Annabella Pittl, Solmaz Etemad, Theresia Dunzendorfer-Matt, Klaus Scheffzek, Klaus R. Liedl, Pidder Jansen‐Dürr   +12 more
openalex   +2 more sources

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]. [PDF]

PLoS One, 2020
Clarke SJ, Burge M, Feeney K, Gibbs P, Jones K, Marx G, Molloy MP, Price T, Reece WHH, Segelov E, Tebbutt NC.   +10 more
europepmc   +1 more source